Harnessing Coordinated CD4⁺ and CD8⁺ T-Cell Immunity for Virus-Specific Adoptive Immunotherapy in Africa
Virus-specific T-cell (VST) therapy has developed principally for persistent or reactivating viral infections in immunocompromised patients, with the strongest clinical experience involving cytomegalovirus, Epstein–Barr virus, human adenovirus, BK polyomavirus and human herpesvirus 6. Whether this approach can be exten...